2016
DOI: 10.1177/2055102915624873
|View full text |Cite
|
Sign up to set email alerts
|

Trajectories of depressive symptoms after a major cardiac event

Abstract: Depression is a common comorbidity in cardiac patients. This study sought to document fluctuations of depressive symptoms in the 12 months after a first major cardiac event. In all, 310 patients completed a battery of psychosocial measures including the depression subscale of the Symptom Check List-90-Revised. A total of 252 of them also completed follow-up measures at 3 and 12 months. Trajectories of depressive symptoms were classified as none, worsening symptoms, sustained remission, and persistent symptoms.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 40 publications
1
8
0
Order By: Relevance
“…Moreover, this research has revealed that adult respondents who reported absence of cardiovascular diseases demonstrated significantly lower scores for negative emotions and significantly higher scores for flourishing, life satisfaction, positive emotions, psychological capital, self-efficacy, hope, resilience, and optimism than those who reported cardiovascular diseases which is in line with many other findings ( Besharat et al, 2018 ; Boehm and Kubzansky, 2012 ; Gaitan-Sierra and Hyland, 2011 ; Hall et al, 2010 ; Mittag et al, 2016 ).…”
Section: Discussionsupporting
confidence: 87%
See 2 more Smart Citations
“…Moreover, this research has revealed that adult respondents who reported absence of cardiovascular diseases demonstrated significantly lower scores for negative emotions and significantly higher scores for flourishing, life satisfaction, positive emotions, psychological capital, self-efficacy, hope, resilience, and optimism than those who reported cardiovascular diseases which is in line with many other findings ( Besharat et al, 2018 ; Boehm and Kubzansky, 2012 ; Gaitan-Sierra and Hyland, 2011 ; Hall et al, 2010 ; Mittag et al, 2016 ).…”
Section: Discussionsupporting
confidence: 87%
“…Based on the literature, we have chosen to investigate a sample of adults, and we assumed that any illness experience diminishes psychological wellbeing as psychological wellbeing is related to health ( Boehm and Kubzansky, 2012 ; Cimpean and David, 2019 ; Costanzo et al, 2009 ; Di Giuseppe et al, 2019 ; Fredrickson, 2000 ; Gick, 2011 ; Lai and Ma, 2016 ; Levin, 2013 ; Ma and Lai, 2018 ; Mittag et al, 2016 ; Røysamb et al, 2003 ; Schöllgen et al, 2016 ; Sibulwa et al, 2019 ; Staudinger et al, 1999 ; Wiest et al, 2011 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is important because patients with CVD who report low trust in their healthcare professional are at a higher risk of experiencing worsening of their depressive symptoms. 30 Furthermore, patients with HF who still have, or have developed, depressive symptoms 18 months after discharge from the hospital are at a higher risk of a worsening prognosis. 31 This highlights the importance of seeing the patient as a whole and not only as a heart disease.…”
Section: Discussionmentioning
confidence: 99%
“…However, the type of disease, psychiatric or not, might not be the only risk factor of non-recommended use since chronicity and severity might also impact the risk of non-recommended benzodiazepine use. Indeed, patients with non-psychiatric chronic diseases such as cancer [15][16][17], cardiovascular diseases [18][19][20] or diabetes [21][22][23] use benzodiazepines more often than the general population [24][25][26][27]. It is therefore questionable whether the risk of use non-compliant with guidelines is increased in these particularly vulnerable populations with psychiatric or non-psychiatric conditions, and whether the increase in this risk is similar across these different chronic diseases.…”
Section: Introductionmentioning
confidence: 99%